1. France Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Clariane SE

Clariane SE

3.12
EUR
-0.14
(-4.44%)
1.49BMarket Cap
Mar 04Next Earn
Clariane SE
IOB:0OPS
(London Stock Exchange (International))

Recent

price

3.12

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
16.39
17.56
18.56
22.72
16.16
18.58
21.32
22.13
23.34
25.28
25.54
24.5
26.41
29.28
22.83
14.9
- -
Revenue per Share
0.48
0.37
0.39
0.48
0.45
0.42
0.94
1.15
0.86
0.8
0.27
0.54
0.13
-0.62
-0.24
- -
- -
Basic EPS, GAAP
1.51
1.7
0.89
-0.05
0.98
0.76
1.06
1.39
0.79
0.9
1.86
1.84
1.42
-1.03
1.26
2.29
- -
Free Cash Flow per Basic Share
0.33
0.34
0.08
0.13
0.22
0.25
0.21
0.22
0.17
0.17
0.07
0.22
0.34
0.39
0.22
0.2
- -
Dividend per Share
12.55
12.37
12.05
12.33
13.88
13.94
14.54
17.52
17.97
17.82
18.75
20.74
20.87
20.98
10.38
10.14
10.13
Book Value per Share
-10.14
-11.78
-10.36
-10.83
-10.4
-10.77
-13.44
-10.79
-11.1
-13.16
-11.32
-11.29
-11.52
-11.98
-5.29
-4.68
-4.65
Tangible Book Value per Share
56
58
60
60
138
139
140
141
143
143
148
169
168
171
231
357
357
Basic Weighted Avg Shares
923
1,015
1,108
1,356
2,222
2,573
2,981
3,131
3,336
3,613
3,773
4,137
4,438
4,996
5,282
5,310
- -
Sales/Revenue/Turnover
7.89
7.81
6.94
7.89
9.2
6.83
7.82
8.9
9.11
9.82
4.79
9.75
7.54
6.34
5.44
5.35
- -
Operating Margin (%)
32
32
48
58
98
146
160
176
142
460
525
613
617
750
704
838
- -
Depreciation Expense
27
22
23
29
61
59
131
163
123
115
39
91
22
-105
-55
2
- -
Net Income, GAAP
39.53
44.34
50.92
43.13
39.92
46.52
- -
- -
29.61
33.78
28.6
8.57
20.99
- -
- -
- -
- -
Effective Tax Rate (%)
2.94
2.14
2.1
2.11
2.76
2.28
4.4
5.22
3.69
3.17
1.04
2.2
0.5
-2.11
-1.04
0.03
- -
Profit Margin (%)
-160
-213
-106
-281
-338
-72
-427
-355
-393
-1,026
-732
-245
-1,044
-887
-1,267
-701
-446
Working Capital
532
623
665
712
1,638
2,069
2,442
2,498
2,861
5,723
6,398
7,187
6,932
7,105
6,587
6,775
6,944
LT Debt
718
723
733
768
1,903
1,934
2,037
2,475
2,568
2,570
3,323
3,764
3,868
3,937
4,021
3,902
3,917
Total Equity
3.46
3.27
2.91
3.68
4.13
2.45
- -
- -
3.75
3.16
1.87
2.7
1.77
- -
- -
- -
- -
Return on Invested Capital (%)
3.32
2.85
2.56
3.36
3.41
2.2
- -
- -
3.43
2.97
1.75
2.11
1.39
- -
- -
- -
- -
Return on Capital (%)
3.9
3.09
3.29
3.92
4.62
3.07
6.65
7.28
4.91
4.48
1.38
2.74
0.63
-2.96
-1.52
0.04
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
1,403
1,032
1,402
LT Borrowings
3,310
1,807
3,460
LT Finance Leases
3,495
4,968
3,484
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
356
357
357
Market Capitalization
1,856
1,386
1,487

Working Capital

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
2,093
1,732
2,360
Cash, Cash Equivalents & STI
752
822
1,412
Accounts Receivable, Net
484
411
445
Inventories
37
36
33
Total Current Liabilities
2,984
2,433
2,806
Payables & Accruals
- -
- -
- -
ST Debt
1,403
1,032
1,402
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.7%
3.4%
-2.96%
Free Cash Flow
-11.18%
-54.07%
179.35%
Net Income, GAAP
-62.12%
-134.43%
-102.89%
Sales/Revenue/Turnover
7.59%
7.15%
0.54%
Total Cash Common Dividend
25.41%
68.59%
37.76%

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
5,282
2025
- -
- -
5,310
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.24
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.22
2025
- -
- -
0.2
2026
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Clariane SE (CLARI.PA) operates as Europe's leading community for care, healthcare, and hospitality services targeting vulnerable individuals, including the elderly and those requiring specialized medical support; it provides long-term care through 666 nursing homes and residential facilities accommodating nearly 90,000 residents annually (Korian networks, Seniors Residencias); specialty care via 277 healthcare facilities serving over 700,000 patients yearly with full-time hospitalization, day hospitalization, outpatient care, home hospitalization, post-acute and rehabilitation services, mental health clinics, and hospital-at-home networks (Inicea, Grupo 5, Ita Salud Mental); and community care encompassing shared living solutions, assisted living residences, home care services, and home nursing through more than 80,000 supported individuals in shared housing and agencies (Âges & Vie). The company, founded in 2001 and headquartered at 21-25 rue Balzac in Paris, France, employs approximately 63,000 professionals across six European countries including France, Germany, Belgium, Italy, the Netherlands, and Spain, delivering personalized support aligned with its purpose of caring for each person's humanity in times of vulnerability. Formerly known as Korian, it rebranded to Clariane SE in June 2023, becoming a purpose-driven entity, and in June 2025 completed a €1 billion asset disposal program ahead of schedule by selling its Petits-fils home care network—expanded to 292 branches serving 39,000 clients since its 2018 acquisition—to Crédit Agricole Santé & Territoires for €345 million enterprise value, while exploring a nationwide service partnership; this strengthens its financial structure alongside a February 2025 syndicated loan extension, supporting the "At Your Side" corporate project and "Better Support" program amid ongoing network restructuring and European expansion.